Business Overview: Plexus Corp. (NASDAQ: PLXS)

---

Executive Summary

Plexus Corp. designs, manufactures, and services highly complex electronic products for customers operating in demanding regulatory environments — primarily industrial, healthcare/life sciences, and aerospace/defense end markets. Rather than competing as a high-volume, low-complexity contract manufacturer, Plexus positions itself around the full product lifecycle: design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services such as repair and spare parts management.

The company matters as a specialist within the broader electronic manufacturing services (EMS) industry, generating $4.03 billion in fiscal 2025 revenue with a GAAP operating margin of 5.0% across a global manufacturing footprint of 26 active facilities and more than 20,000 employees, serving roughly 190 customers with no single customer exceeding 10% of sales — a deliberately diversified, complexity-oriented business model rather than a volume-driven one.

---

1. Core Business Model & How They Work

Plexus engages with customers across the full product lifecycle rather than simply manufacturing to a finished design, often procuring and warehousing materials itself (turnkey) though some work is done on a consignment basis where the customer supplies materials.

[ Design & Development ] ➡️ [ Supply Chain Solutions ] ➡️ [ New Product Introduction ] ➡️ [ Manufacturing (Turnkey or Consignment) ] ➡️ [ Sustaining Services (Repair, Spare Parts) ]

Key Operational Drivers

1. Focus on regulated, complex products: By design, Plexus targets customers in industrial, healthcare/life sciences, and aerospace/defense — markets where regulatory compliance and product complexity matter more than high-volume, low-mix manufacturing.
2. Turnkey materials management: Procuring and warehousing most materials itself lets Plexus manage supply chain risk directly for customers rather than simply assembling customer-supplied parts.
3. Global, balanced manufacturing footprint: 26 active facilities (18 manufacturing facilities and six design centers) spanning the Americas, Asia-Pacific, and EMEA, including significant capacity in Penang, Malaysia, and Mexican facilities operating under the IMMEX program, support both cost efficiency and proximity to end markets.
4. Customer diversification by design: With about 190 customers and no single customer exceeding 10% of sales in fiscal 2025 or 2024, Plexus deliberately avoids the customer-concentration risk common among EMS peers tied to one or two large accounts.

---

2. Business Segments

Plexus reports primarily by end market rather than discrete legal segments:

┌───────────────────────────────────────┐
│             Plexus Corp.                 │
│     FY2025 Revenue: $4.03 billion          │
└──────────────────────┬────────────────────┘
                        │
   ┌────────────────────┼────────────────────┐
   ▼                    ▼                    ▼
┌──────────────┐ ┌──────────────────┐ ┌─────────────────┐
│ Industrial     │ │ Healthcare/        │ │ Aerospace/        │
│ 43% of sales    │ │ Life Sciences       │ │ Defense             │
│                 │ │ 40% of sales         │ │ 17% of sales,        │
│                 │ │                       │ │ down from 18%         │
└──────────────┘ └──────────────────┘ └─────────────────┘

Industrial is the largest end market, covering a broad range of complex industrial electronics. Healthcare/Life Sciences is nearly as large and reflects Plexus's positioning in heavily regulated medical device manufacturing. Aerospace/Defense is the smallest of the three but operates in an even more demanding regulatory and qualification environment, and its share declined slightly year-over-year.

---

3. Product Portfolio

---

4. Competitive Landscape

Plexus competes against both global and regional EMS providers as well as customers' own in-house manufacturing capabilities. The company explicitly acknowledges that some competitors have greater resources, lower cost structures, stronger buying power, or the willingness to accept lower margins — meaning Plexus does not attempt to win on price. Instead, it positions its full-lifecycle service model and global footprint as the basis for competing in low-volume, highly complex, regulated work that typically requires more inventory investment and SG&A spending than high-volume EMS production.

---

5. Strategic Strengths & Risks

Competitive Strengths (The Moat)

• Deep regulatory and quality expertise: Serving aerospace/defense and healthcare/life sciences customers requires certifications and quality systems that are difficult and time-consuming for a new entrant to build.
• Customer diversification: No single customer over 10% of sales, with the top ten customers at just 49.1% of fiscal 2025 revenue, meaningfully reduces concentration risk relative to EMS peers.
• Global, balanced manufacturing footprint: Facilities spanning the Americas, Asia-Pacific, and EMEA — including Penang, Malaysia and IMMEX-program Mexican sites — support both cost efficiency and geographic resilience.
• Full-lifecycle engagement: Involvement from design through sustaining services creates multiple, reinforcing touchpoints with each customer relationship over a product's life.

Strategic Risks

• Explicit cost disadvantage versus some competitors: Plexus itself acknowledges that some rivals have lower cost structures and are willing to accept lower margins, meaning it must continuously justify a premium through service quality and complexity handling.
• Working capital intensity: The low-volume, high-mix, regulated nature of its work requires higher inventory and SG&A investment than high-volume EMS production, pressuring near-term returns on capital.
• Aerospace/Defense softness: The segment's share of sales declined from 18% to 17% year-over-year, a trend worth monitoring given the segment's otherwise strong growth profile in the broader industry.
• Customer requalification cycles: While high switching costs protect existing relationships, winning new regulated-industry customers also requires a long, costly sales and qualification cycle that limits how quickly Plexus can diversify its customer base further.

---

6. Financial Overview

---

7. Summary Conclusion

Plexus has built a genuine moat around manufacturing complexity and regulatory compliance rather than scale or low cost — a position reinforced by deep qualification requirements in healthcare, aerospace/defense, and complex industrial electronics that make customers slow and costly to win, but also slow and costly to lose once won. The company's own acknowledgment that some competitors undercut it on cost means Plexus's long-term success depends on continuing to prove that its full-lifecycle service model and quality systems are worth the premium its working-capital-intensive business model requires.